Search

Your search keyword '"Rathi V. Iyer"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Rathi V. Iyer" Remove constraint Author: "Rathi V. Iyer" Topic medicine.disease Remove constraint Topic: medicine.disease
53 results on '"Rathi V. Iyer"'

Search Results

1. Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke

2. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

Catalog

Books, media, physical & digital resources

3. Protein-Losing Enteropathy due to Intestinal and Colonic Involvement With Langerhans Cell Histiocytosis and Review of the Literature

4. Stroke with intracranial stenosis is associated with increased platelet activation in sickle cell anemia

5. Impact of hydroxyurea on clinical events in the BABY HUG trial

6. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure

7. Influence of severity of anemia on clinical findings in infants with sickle cell anemia: Analyses from the BABY HUG study

8. Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload

9. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial

10. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: Baseline data from the BABY HUG trial

11. The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design

12. Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea (BABY HUG)

13. Nocturnal Enuresis and Psychosocial Problems in Pediatric Sickle Cell Disease and Sibling Controls

14. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003

15. Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities

16. Does weight reduction in haemophilia lead to a decrease in joint bleeds?

17. Influence of Penicillin Prophylaxis on Antimicrobial Resistance in Nasopharyngeal S. Pneumoniae among Children with Sickle Cell Anemia

18. Outcome of overt stroke in sickle cell anaemia, a single institution's experience

19. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: Effects of continued penicillin prophylaxis

20. Discontinuing penicillin prophylaxis in children with sickle cell anemia

21. A Comparison of Conservative and Aggressive Transfusion Regimens in the Perioperative Management of Sickle Cell Disease

22. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)

23. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia

24. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

25. Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi

26. Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience

27. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury

28. Inhibitors of Factor VIII in Black Patients with Hemophilia

29. Adherence to study medication and visits: Data from the BABY HUG trial

30. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease

31. Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution

32. Implementation of the STOP protocol for Stroke Prevention in Sickle Cell Anemia by using duplex power Doppler imaging

33. Clinical characteristics of children with hereditary hemolytic anemias and aplastic crisis: a 7-year review

34. The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

35. Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

36. Refining Th Predictive Value of Secretory Phospholipase A2 In Sickle Cell Disease Patients with Acute Chest Syndrome

37. Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

38. Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

39. Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia

40. Serum Cystatin-C Levels in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

41. Transcranial Doppler (TCD) Ultrasonography in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

42. Urine Concentrating Ability in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

43. PEARSON SYNDROME

44. Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study

45. Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial

46. TCD in Infants: A Report from the BABY HUG Trial

47. Evaluation of Renal Function by Glomerular Filtration Rate (GFR) in Infants with Sickle Cell Anemia

49. Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia

50. beta-Thalassemia present in cis to a new beta-chain structural variant, Hb Vicksburg [beta 75 (E19)Leu leads to 0]